Author: Lu, Yan; Jiang, Yun; Ling, Lijun; Zhang, Yunyi; Li, Hong; Chen, Daofeng
Title: Beneficial effects of Houttuynia cordata polysaccharides on “two-hit” acute lung injury and endotoxic fever in rats associated with anti-complementary activities Document date: 2017_12_8
ID: q4r36tpw_51
Snippet: The in vitro experiments clearly revealed that CHCP is a potent anti-complementary agent affecting both classical pathway and the alternative pathway by selectively blocking the key components C3 and C4 in the complement activation cascade. As demonstrated in the literature, C3 functions to activate both the classical and alternative pathways and makes up 70% of the total protein in the complement system 30 . C4, the second most abundant compleme.....
Document: The in vitro experiments clearly revealed that CHCP is a potent anti-complementary agent affecting both classical pathway and the alternative pathway by selectively blocking the key components C3 and C4 in the complement activation cascade. As demonstrated in the literature, C3 functions to activate both the classical and alternative pathways and makes up 70% of the total protein in the complement system 30 . C4, the second most abundant complement protein in serum, is a glycoprotein which functions as the limited activation step in the activation of the classical pathway 2 . It suggested that CHCP could be effective in treating the complement-associated diseases. ALI is a life-threatening complication of various systemic inflammations and of pulmonary disorders that can cause a mortality rate of 30-40% 9 . The current main treatment against ALI has been the application of glucocorticoids, which often lead to severe adverse reactions during the long treatment.
Search related documents:
Co phrase search for related documents- activation step and alternative pathway: 1, 2
- activation step and alternative pathway classical pathway: 1
- activation step and classical pathway: 1
- activation step and complement activation: 1
- activation step and total protein: 1
- adverse reaction and complement protein: 1
- adverse reaction and long treatment: 1, 2
- adverse reaction and main treatment: 1, 2
- adverse reaction and mortality rate: 1, 2, 3
- adverse reaction and severe adverse reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- alternative classical pathway and classical pathway: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- alternative classical pathway and complement activation: 1, 2, 3, 4, 5, 6, 7
- alternative classical pathway and complement system: 1, 2, 3, 4, 5, 6
- alternative classical pathway and total protein: 1
- alternative pathway and classical pathway: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- alternative pathway and complement activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- alternative pathway and complement protein: 1, 2, 3, 4, 5, 6, 7, 8
- alternative pathway and complement system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- alternative pathway and long treatment: 1
Co phrase search for related documents, hyperlinks ordered by date